Video Experimental Relacionado
Updated: Jan 13, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
Revisión de la inflamación de tipo 2 y la hiperreactividad de las vías respiratorias en la EPOC
Philipp Suter1, Robert Greig1, Rory Chan1
1Scottish Centre for Respiratory Research, School of Medicine, University of Dundee, Dundee, United Kingdom.
The journal of allergy and clinical immunology. In practice
|January 9, 2026
Resumen
La hiperreactividad de las vías respiratorias (HVR) en la enfermedad pulmonar obstructiva crónica (EPOC) está relacionada con la inflamación de tipo 2 y puede beneficiarse de terapias dirigidas. Se necesita más investigación para aclarar su papel en el manejo personalizado de la EPOC.
Área de la Ciencia:
- Neumología y Medicina Respiratoria; Inmunología Clínica; Farmacología
Sus antecedentes:
- La hiperreactividad de las vías respiratorias (HVR), común en el asma, está poco reconocida en la enfermedad pulmonar obstructiva crónica (EPOC).; El creciente reconocimiento de la heterogeneidad de la EPOC, incluida la EPOC eosinofílica y el solapamiento asma-EPOC, destaca la HVR como un marcador de inflamación de tipo 2 (T2).; Este fenotipo T2 alto afecta al 20-40% de los pacientes con EPOC, lo que impulsa el interés en los biológicos dirigidos a IL-4, IL-5, IL-13 y TSLP.
Objetivo del estudio:
- Revisar la evidencia actual sobre la HVR en la EPOC.; Explorar la relación entre la HVR, los fenotipos inflamatorios, los métodos de diagnóstico y las implicaciones terapéuticas en la EPOC.; Evaluar la HVR como un posible rasgo tratable en el manejo de la EPOC.
Principales métodos:
- Revisión de la literatura existente sobre la HVR en la EPOC.; Análisis de las modalidades de diagnóstico: desafíos directos (p. ej., metacolina) que evalúan la geometría de las vías respiratorias frente a desafíos indirectos (p. ej., manitol) que reflejan la inflamación T2.; Correlación de la HVR con marcadores inflamatorios como los eosinófilos y el óxido nítrico exhalado fraccional (FeNO).
Principales resultados:
- La HVR en la EPOC implica mecanismos estructurales e inflamatorios.; Los desafíos indirectos se correlacionan mejor con los marcadores de inflamación T2 (eosinófilos, FeNO) que los desafíos directos.; Los pacientes con HVR pueden responder mejor a los corticosteroides inhalados; los biológicos son prometedores pero requieren ensayos específicos de EPOC.
Conclusiones:
- La HVR es un rasgo clínicamente relevante en la EPOC, especialmente en fenotipos T2 altos.; Los desafíos estandarizados de HVR, la integración de marcadores inflamatorios y los ensayos biológicos dirigidos son cruciales para el manejo personalizado de la EPOC.; La HVR representa un rasgo tratable prometedor para optimizar la terapia de la EPOC.
Palabras clave:
Hiperreactividad de las vías respiratoriasSolapamiento asma-EPOCEPOCInflamación de tipo 2Más Videos Relacionados
Videos de Conceptos Relacionados
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
719
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
719
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K